Freestone Grove Partners’s Option Care Health OPCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33.4M Buy
1,239,573
+323,675
+35% +$10.5M 0.24% 146
2025
Q4
$29.2M Buy
+915,898
New +$26.9M 0.21% 160
2025
Q3
Sell
-1,156,164
Closed -$37.6M 854
2025
Q2
$37.6M Buy
1,156,164
+437,834
+61% +$14.1M 0.28% 133
2025
Q1
$25.1M Sell
718,330
-35,421
-5% -$1.11M 0.26% 145
2024
Q4
$17.5M Buy
+753,751
New +$19M 0.21% 151

Other funds holding OPCH

Freestone Grove Partners's OPCH Position: Q1 2026 in Review

Freestone Grove Partners increased its Option Care Health (OPCH) stake by 35% in Q1 2026, buying an estimated $10.5M and bringing the position to 1,239,573 shares worth $33.4M. The position accounts for 0.24% of the portfolio, ranked #146.

Freestone Grove Partners first reported a position in OPCH in Q4 2024 and has held it in 5 quarters since. The position peaked at $37.6M in Q2 2025. 369 funds tracked by Wall St. Rank hold OPCH as of Q1 2026.

  • Freestone Grove Partners held 1,239,573 shares of Option Care Health worth $33.4M as of Q1 2026.
  • Freestone Grove Partners bought 323,675 Option Care Health shares in Q1 2026, an estimated $10.5M.
  • Option Care Health made up 0.24% of Freestone Grove Partners's portfolio in Q1 2026, its #146 holding.
  • Freestone Grove Partners first reported a position in Option Care Health in Q4 2024 and has held it in 5 quarters since.
  • Freestone Grove Partners's Option Care Health position peaked at $37.6M in Q2 2025.
  • 369 funds tracked by Wall St. Rank held Option Care Health as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.